Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DEXCOM INC | Director | Common Stock | 63.3K | $7.83M | $123.63 | May 18, 2023 | by Partnership |
DEXCOM INC | Director | Common Stock | 40K | $4.95M | $123.63 | May 18, 2023 | by Spouse |
Applied Therapeutics, Inc. | Director | Common Stock | 65K | $276K | $4.24 | Jun 6, 2024 | Direct |
SAB Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 35K | Jul 15, 2024 | Direct | ||
DEXCOM INC | Director | Common Stock | 0 | $123.63 | May 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics, Inc. | Jul 15, 2024 | 2 | $0 | 4 | Jul 17, 2024 | Director |
APLT | Applied Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
SABS | SAB Biotherapeutics, Inc. | May 3, 2024 | 0 | $0 | 3 | May 14, 2024 | Director |
APLT | Applied Therapeutics Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
DXCM | DEXCOM INC | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
APLT | Applied Therapeutics Inc. | Aug 2, 2022 | 8 | $0 | 4 | Aug 4, 2022 | Director |
APLT | Applied Therapeutics Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Director |
DXCM | DEXCOM INC | May 20, 2022 | 3 | $0.97 | 4 | May 23, 2022 | Director |
DXCM | DEXCOM INC | Jun 22, 2021 | 3 | -$8.53M | 4 | Jun 24, 2021 | Director |
APLT | Applied Therapeutics Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
DXCM | DEXCOM INC | May 21, 2021 | 3 | $0.90 | 4 | May 25, 2021 | Director |